|
|
|
 |
- Keenly exploring options of Strategic Partnerships, acquisitions & JV's in select markets.
- Tie-up for drug development and contract manufacturing.
|
|
|
 |
|
| Alkem has successfully inlicenced several patented molecules from international companies vis Oxum (Oculus Innovative Science, USA), Cytobrush (Cooper Surgical, USA), Pycnogenol (Hor Phag, Switzerland) etc. Many more inlicencing deals are at advanced stages of discussion, encompassing several therapeutic groups. |
|
|
|
|
|
